Association between plasma bilirubin and mortality

Libor Vı́tek(Charles University), Martin Bobák(Masaryk University), Andrzej Pająk(Jagiellonian University), Magdalena Kozela(Jagiellonian University), Agnieszka Doryńska(Institute of Cardiology), Vilém Danzig(Palacký University Olomouc), Dénes Stefler(University College London), Jaroslav A. Hubáček(Institute of Clinical and Experimental Medicine), Lenka Eremiášová(Charles University)
Annals of Hepatology
March 1, 2019
10.1016/j.aohep.2019.02.001
Cited by 42

Related Papers

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
|The Lancet|2014|713
Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data
|BMJ|2014|677
Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium
|BMJ|2015|551
Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts
|Circulation|2017|452